Inflammation of the Aorta; Afib in the Hospital Also in TTHealthWatch: standards for osteoporosis screening and HbA1c in premenopausal women Oct 07, 2023 podcast
CPAP Turns in Mixed Results for Patients With Diabetic Eye Disease Slower progression of retinal disease, but an increase in microhemorrhages Oct 06, 2023
Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Risk Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
Faster-Acting Insulin Aspart Safe for Pregnant Women With Diabetes The faster formulation led to fewer hypoglycemia events versus conventional insulin aspart Oct 06, 2023
Adherence Matters for CVD Secondary Prevention in CPAP Users Questionable benefit may hinge on number of hours used Oct 05, 2023
Hybrid Closed-Loop Insulin System for T1D Safe, Effective During Pregnancy However, no FDA-approved systems have a pregnancy indication yet Oct 05, 2023
Mixed Bag for Early Metformin in Gestational Diabetes EMERGE trial misses on primary endpoint, but secondary outcomes suggest potential benefit Oct 03, 2023
Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2D Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
Repeat Tests for Inflammation Aid Prognosis After Acute Heart Failure Mortality predicted by cumulative hsCRP levels over time Oct 02, 2023
FDA OKs Another Injectable for Rare Kidney Disorder Nedosiran approved for patients ages 9 years and older with primary hyperoxaluria type 1 Oct 02, 2023
FDA Adds Intestinal Blockage Reports to Ozempic Labeling Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugs Lower risk compared with DPP-4 inhibitors, and similar risk versus GLP-1 receptor agonists Sep 26, 2023
FDA Approves Another SGLT2 Inhibitor for Treating CKD Empagliflozin adds indication in adults, regardless of diabetes status Sep 22, 2023
FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetes We haven't seen "the best version of this device," said panel member Sep 22, 2023
Reassuring Registry Data on Going Into TAVR Sans Symptoms Would intervention beat watchful waiting for asymptomatic patients with severe aortic stenosis? Sep 20, 2023
Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise. Advisory committee to weigh in on safety concerns with GLP-1 receptor agonist implant Sep 20, 2023
Direct-to-Consumer Lab Tests Raise Ethical Questions, Researchers Say Privacy policies, terms of sale often are unclear Sep 18, 2023
Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
No Avoiding Mitral Valve Implant Obstruction With Preemptive Ablation LVOT obstruction remains thorn in the side of TMVI in small case series Sep 15, 2023
Fresh Blood Not Always the Best Blood? French study assesses red blood cell transfusions and kidney transplant outcomes Sep 14, 2023
FDA Panel Reluctantly Backs Patisiran for ATTR Cardiomyopathy Clinical meaningfulness is a different question, however Sep 13, 2023
Mask Attack Leaves Actor Blind; Diabetes Risk in Night Owls; U.S. Blood Shortage Health news and commentary from around the Web gathered by 51˶ staff Sep 12, 2023
One PrEP Regimen Linked to Higher Risk of Hypertension, Statin Use Over Another Use of TAF associated with increased risks within 2 years versus TDF, retrospective study finds Sep 11, 2023
When Temps Rise, So Do Medical Risks. Should Docs and Nurses Talk More About Heat? "This is not your grandmother's heat," says policy expert Sep 10, 2023
Lorundrostat Stands a Chance Against Obesity-Related Hypertension Selective aldosterone synthase inhibitor proceeds to phase III study after Target-HTN's success Sep 10, 2023
Optimal BP After Stroke; Psilocybin for Depression Also in TTHealthWatch: culprit vessel or complete revascularization? Sep 09, 2023 podcast
New Weight-Loss Drugs Spark Debate About Safety During Surgery Some anesthesiologists think current guidelines don't go far enough Sep 08, 2023
Calcium Channel Blockers Again Linked to Glaucoma But researcher says there's no need to switch most users to other antihypertensive drugs Sep 07, 2023
Low-Dose Semaglutide Can Ease Insulin Need in Early T1D, Small Series Shows All 10 patients were able to eliminate prandial insulin use within 3 months Sep 06, 2023
Predicting ICU Outcomes; Post-Stroke Brain Stimulation Also in TTHealthWatch: effect of frailty on intensive blood pressure control Sep 02, 2023 podcast
Novel Amyloid Drug Improves Mid-Term Outcomes in ATTR Cardiomyopathy Pivotal trial "suggests the tantalizing possibility of genuine clinical improvement" Aug 29, 2023
'Big Win' for Anti-Obesity Medication in Heart Failure Semaglutide led to meaningful reductions in symptoms, weight in patients with obesity and HFpEF Aug 29, 2023 video
U.S. Unveils First 10 Drugs for Medicare Price Negotiations Treatments for heart failure, Crohn's disease, and diabetes make the list Aug 29, 2023
Compound in Beetroot Juice Fends Off Contrast-Induced AKI "Provocative" results for inorganic nitrate pill shown in NITRATE-CIN trial Aug 29, 2023
Case Grows for SGLT2 Inhibitors as Gout Treatment Large cohort study shows expansive benefits Aug 28, 2023
Afib Ablation Exceeds Expectations in Sickest Heart Failure Patients Death and surgeries delayed in end-stage heart failure Aug 28, 2023
CRT-D Upgrade Suits Patients With Pacing-Related Heart Failure BUDAPEST-CRT Upgrade is the first major trial on upgrade strategy Aug 27, 2023
Iron Infusions Narrowly Miss the Mark for Clinical Benefit in Heart Failure Hard endpoints do not favor IV ferric carboxymaltose in well-powered HEART-FID Aug 26, 2023
SGLT2 Inhibitors, Rapid Titration, IV Iron Get a Boost in New European HF Guideline Other recommendations also released for endocarditis, cardiomyopathies, ACS, and more Aug 25, 2023
Wegovy Reduces Heavy Symptom Burden of Obesity-Related Heart Failure Heart failure with preserved ejection fraction and obesity becoming more common Aug 25, 2023
